Annual Cash & Cash Equivalents
$159.71 M
-$97.94 M-38.01%
December 31, 2023
Summary
- As of February 8, 2025, ACET annual cash & cash equivalents is $159.71 million, with the most recent change of -$97.94 million (-38.01%) on December 31, 2023.
- During the last 3 years, ACET annual cash & cash equivalents has risen by +$75.38 million (+89.39%).
- ACET annual cash & cash equivalents is now -42.46% below its all-time high of $277.54 million, reached on December 31, 2021.
Performance
ACET Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$105.48 M
-$118.59 M-52.92%
September 30, 2024
Summary
- As of February 8, 2025, ACET quarterly cash and cash equivalents is $105.48 million, with the most recent change of -$118.59 million (-52.92%) on September 30, 2024.
- Over the past year, ACET quarterly cash and cash equivalents has dropped by -$77.78 million (-42.44%).
- ACET quarterly cash and cash equivalents is now -62.68% below its all-time high of $282.68 million, reached on September 30, 2022.
Performance
ACET Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ACET Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.0% | -42.4% |
| 3 y3 years | +89.4% | -42.4% |
| 5 y5 years | - | -42.4% |
ACET Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -42.5% | at low | -62.7% | at low |
| 5 y | 5-year | -42.5% | +1405.7% | -62.7% | +894.5% |
| alltime | all time | -42.5% | +9881.9% | -62.7% | +894.5% |
Adicet Bio Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $105.48 M(-52.9%) |
| Jun 2024 | - | $224.07 M(-9.5%) |
| Mar 2024 | - | $247.59 M(+55.0%) |
| Dec 2023 | $159.71 M(-38.0%) | $159.71 M(-12.8%) |
| Sep 2023 | - | $183.26 M(-10.8%) |
| Jun 2023 | - | $205.46 M(-11.3%) |
| Mar 2023 | - | $231.64 M(-10.1%) |
| Dec 2022 | $257.66 M(-7.2%) | $257.66 M(-8.9%) |
| Sep 2022 | - | $282.68 M(+8.5%) |
| Jun 2022 | - | $260.64 M(-6.2%) |
| Mar 2022 | - | $277.88 M(+0.1%) |
| Dec 2021 | $277.54 M(+229.1%) | $277.54 M(+44.4%) |
| Sep 2021 | - | $192.23 M(-7.9%) |
| Jun 2021 | - | $208.73 M(-5.8%) |
| Mar 2021 | - | $221.67 M(+162.9%) |
| Dec 2020 | $84.33 M(+695.0%) | $84.33 M(-0.7%) |
| Sep 2020 | - | $84.96 M(+701.0%) |
| Dec 2019 | $10.61 M(-89.5%) | $10.61 M |
| Jun 2018 | $100.87 M(+81.2%) | - |
| Jun 2017 | $55.68 M(-16.7%) | - |
| Jun 2016 | $66.83 M(+96.4%) | - |
| Jun 2015 | $34.02 M(-20.7%) | - |
| Jun 2014 | $42.90 M(+29.1%) | - |
| Jun 2013 | $33.23 M(+33.7%) | - |
| Jun 2012 | $24.86 M(-13.3%) | - |
| Jun 2011 | $28.66 M(-7.1%) | - |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2010 | $30.85 M(-46.6%) | - |
| Jun 2009 | $57.76 M(+24.2%) | - |
| Jun 2008 | $46.52 M(+43.9%) | - |
| Jun 2007 | $32.32 M(-4.2%) | - |
| Jun 2006 | $33.73 M(+69.1%) | - |
| Jun 2005 | $19.95 M(-14.5%) | - |
| Jun 2004 | $23.33 M(+15.1%) | - |
| Jun 2003 | $20.26 M(+42.1%) | - |
| Jun 2002 | $14.26 M(+95.0%) | - |
| Jun 2001 | $7.31 M(+160.0%) | - |
| Jun 2000 | $2.81 M(-29.7%) | - |
| Jun 1999 | $4.00 M(-56.5%) | - |
| Jun 1998 | $9.20 M(+124.4%) | - |
| Jun 1997 | $4.10 M(-24.1%) | - |
| Jun 1996 | $5.40 M(+237.5%) | - |
| Jun 1995 | $1.60 M(-68.6%) | - |
| Jun 1994 | $5.10 M(-8.9%) | - |
| Jun 1993 | $5.60 M(-32.5%) | - |
| Jun 1992 | $8.30 M(-26.5%) | - |
| Jun 1991 | $11.30 M(-42.6%) | - |
| Jun 1990 | $19.70 M(-14.0%) | - |
| Jun 1989 | $22.90 M(-3.4%) | - |
| Jun 1988 | $23.70 M(-11.9%) | - |
| Jun 1987 | $26.90 M(+28.7%) | - |
| Jun 1986 | $20.90 M(0.0%) | - |
| Jun 1985 | $20.90 M(+27.4%) | - |
| Jun 1984 | $16.40 M | - |
FAQ
- What is Adicet Bio annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Adicet Bio?
- What is Adicet Bio annual cash & cash equivalents year-on-year change?
- What is Adicet Bio quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Adicet Bio?
- What is Adicet Bio quarterly cash and cash equivalents year-on-year change?
What is Adicet Bio annual cash & cash equivalents?
The current annual cash & cash equivalents of ACET is $159.71 M
What is the all time high annual cash & cash equivalents for Adicet Bio?
Adicet Bio all-time high annual cash & cash equivalents is $277.54 M
What is Adicet Bio annual cash & cash equivalents year-on-year change?
Over the past year, ACET annual cash & cash equivalents has changed by -$97.94 M (-38.01%)
What is Adicet Bio quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ACET is $105.48 M
What is the all time high quarterly cash and cash equivalents for Adicet Bio?
Adicet Bio all-time high quarterly cash and cash equivalents is $282.68 M
What is Adicet Bio quarterly cash and cash equivalents year-on-year change?
Over the past year, ACET quarterly cash and cash equivalents has changed by -$77.78 M (-42.44%)